Michael Conroy
About Michael Conroy
Michael Meekins is the Vice President of R&D at TAE Technologies and TAE Life Sciences, known for his significant contributions to nuclear fusion research and cancer treatment technologies.
Vice President, R&D for TAE Technologies and TAE Life Sciences
Michael Meekins serves as the Vice President of Research and Development for TAE Technologies and TAE Life Sciences. Since joining TAE Technologies in 2005, Michael has played a critical role in the company's growth and technological advancements. Notably, he laid the foundation for the engineering department at TAE before taking part in the international nuclear fusion research project ITER in France. His contributions extend to building advanced machinery and leading significant initiatives within the company.
Background and Industry Contributions
Michael Meekins has a diverse background that includes significant contributions to multiple fields including nuclear fusion and cancer treatment technologies. Before his tenure at TAE Technologies, he worked for Lockheed Martin and Archimedes Technology Group. During his career at TAE, he returned in 2015 to oversee the construction of the C-2W machine. He also played a pivotal role in the coordination, fabrication, and installation of medical particle accelerators for Boron Neutron Capture Therapy (BNCT) in Novosibirsk, Russia and Xiamen, China.
Expertise in Nuclear Fusion and Advanced Manufacturing
Michael Meekins brings a wealth of expertise to his roles, particularly in nuclear fusion safety analysis, risk management, and advanced manufacturing techniques. His skills encompass the fabrication of ultra-high vacuum equipment, high consequence rigging and lifting, welding, machining, and program management. These areas of expertise have made him a critical asset in developing complex engineering systems and ensuring their operational safety and efficacy.
Educational Background and Early Career
Michael Meekins holds a Bachelor of Science degree in aerospace engineering from the University of California, Los Angeles. His early career includes significant roles at Lockheed Martin and Archimedes Technology Group, where he honed his skills in engineering and project management. This solid educational background and early industry experience have underpinned his success in later roles at TAE Technologies and TAE Life Sciences.
Published Research and Patents
Michael Meekins is recognized in the scientific community through his contributions to various respected journals. His research has been published in journals such as Physics of Plasmas, Structural Engineering International, Physics Procedia, and Physical Review Letters. Moreover, he has been named in numerous patents, highlighting his innovative contributions to the fields of nuclear fusion and advanced manufacturing technology.